These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16572445)

  • 21. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
    Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
    J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years.
    Rau R; Herborn G; Zueger S; Fenner H
    J Rheumatol; 2000 Nov; 27(11):2566-75. PubMed ID: 11093435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis.
    Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kamatani N; Kotake S
    Clin Rheumatol; 2007 Dec; 26(12):2137-2141. PubMed ID: 17876645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.
    Rodríguez-Rodríguez L; González-Juanatey C; Palomino-Morales R; Vázquez-Rodríguez TR; Miranda-Filloy JA; Fernández-Gutiérrez B; Llorca J; Martin J; González-Gay MA
    Atherosclerosis; 2011 May; 216(1):125-30. PubMed ID: 21420089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
    Kaltenhäuser S; Pierer M; Arnold S; Kamprad M; Baerwald C; Häntzschel H; Wagner U
    Rheumatology (Oxford); 2007 Jan; 46(1):100-4. PubMed ID: 16728439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis.
    van Krugten MV; Huizinga TW; Kaijzel EL; Zanelli E; Drossaers-Bakker KW; van de Linde P; Hazes JM; Zwinderman AH; Breedveld FC; Verweij CL
    Genes Immun; 1999 Nov; 1(2):91-6. PubMed ID: 11196668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
    Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
    Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study.
    Constantin A; Lauwers-Cancès V; Navaux F; Abbal M; van Meerwijk J; Mazières B; Cambon-Thomsen A; Cantagrel A
    J Rheumatol; 2002 Jan; 29(1):15-20. PubMed ID: 11824952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
    J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohort.
    Vesperini V; Lukas C; Fautrel B; Le Loet X; Rincheval N; Combe B
    Arthritis Care Res (Hoboken); 2013 Dec; 65(12):1899-906. PubMed ID: 23836776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining effects of polymorphism of tumor necrosis factor α 5'-flanking region and HLA-DRB1 on radiological progression in patients with rheumatoid arthritis.
    Ichikawa N; Kotake S; Hakoda M; Higami K; Kawasaki A; Furuya T; Nanke Y; Tsuchiya N; Tokunaga K; Kamatani N
    Mod Rheumatol; 2009 Apr; 19(2):134-139. PubMed ID: 28925311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis.
    Cheung NT; Dawes PT; Poulton KV; Ollier WE; Taylor DJ; Mattey DL
    J Rheumatol; 2000 Apr; 27(4):882-7. PubMed ID: 10782810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
    J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study.
    Combe B; Dougados M; Goupille P; Cantagrel A; Eliaou JF; Sibilia J; Meyer O; Sany J; Daurès JP; Dubois A
    Arthritis Rheum; 2001 Aug; 44(8):1736-43. PubMed ID: 11508423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity.
    Gourraud PA; Boyer JF; Barnetche T; Abbal M; Cambon-Thomsen A; Cantagrel A; Constantin A
    Arthritis Rheum; 2006 Feb; 54(2):593-9. PubMed ID: 16447236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
    van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE
    Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty-Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception Cohorts.
    Carpenter L; Norton S; Nikiphorou E; Jayakumar K; McWilliams DF; Rennie KL; Dixey J; Kiely P; Walsh DA; Young A;
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1809-1817. PubMed ID: 28217885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid arthritis.
    Higami K; Hakoda M; Matsuda Y; Ueda H; Kashiwazaki S
    Arthritis Rheum; 1997 Dec; 40(12):2241-7. PubMed ID: 9416863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis.
    Dörr S; Lechtenböhmer N; Rau R; Herborn G; Wagner U; Müller-Myhsok B; Hansmann I; Keyszer G
    Arthritis Res Ther; 2004; 6(3):R199-207. PubMed ID: 15142265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.